C
Concord Biotech Ltd
PharmaceuticalsSmallcap
About the company
Concord Biotech Limited, a biopharma company, engages in R&D, manufacturing, and marketing of pharmaceutical products in diverse therapeutic segments.
Performance
- Stock
- Loading Stock value
—
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 47.41 | 45.62 |
| PB Ratio | 6.20 | 6.11 |
| Dividend Yield | 0.63% | 0.47% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions